Healthcare - Biotechnology - NASDAQ - CH
$ 8.06
-1.71 %
$ 12.7 M
Market Cap
-0.42
P/E
Price Target
Average
272.21%
Revenue Forecast
Estimate
59.67%
EBIT
Estimate
13.88%
Net Income
Estimate
25.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Addex Therapeutics Ltd
Wall Street analysts predict an average 1-year price target for ADXN of $30 , with forecasts ranging from a low of $30 to a high of $30 .
ADXN Lowest Price Target
Wall Street Target
30 USD
272.21%
ADXN Average Price Target
Wall Street Target
30 USD
272.21%
ADXN Highest Price Target
Wall Street Target
30 USD
272.21%
REVENUE FORECAST
Revenue Forecast Chart ADXN
EBIT FORECAST
EBIT Forecast Chart ADXN
NET INCOME FORECAST
Net Income Chart ADXN